Timolol: Long-term Canadian multicentre study

R. P. LeBlanc, N. E. Saheb, G. Krip

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

8 Citas (Scopus)

Resumen

This paper reports a 200-week-long study of the efficacy of timolol maleate ophthalmic preparations. At centres across Canada 117 patients were studied according to a rigid protocol. Timolol maleate was shown to be an effective antiglaucomatous drug, maintaining the intraocular pressure below 22 mm Hg throughout the study in 137 (60%) of the 227 eyes. No clinically significant effect on the pulse rate or the mean perfusion pressure was demonstrated, and the medication was well tolerated, causing few side effects or adverse reactions.

Idioma originalEnglish
Páginas (desde-hasta)128-130
Número de páginas3
PublicaciónCanadian Journal of Ophthalmology
Volumen20
N.º4
EstadoPublished - 1985

ASJC Scopus Subject Areas

  • Ophthalmology

Huella

Profundice en los temas de investigación de 'Timolol: Long-term Canadian multicentre study'. En conjunto forman una huella única.

Citar esto